K122247

Substantially Equivalent

LIDCORAPID V2 MONITOR

Applicant: Lidco, Ltd.
Product code: DXG
Advisory panel: Cardiovascular
Date received: 2012-07-27
Decision date: 2013-03-20
Decision: Substantially Equivalent
Clearance type: Traditional
Location: London, GB

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.